Overview of the systematic reviews with network meta-analysis evaluating the efficacy or safety of the systemic treatments in moderate-to-severe psoriasis

被引：0
|
作者：
Guelimi, Robin [1 ]
Afach, Sivem [1 ]
Regnaux, Jean-Philippe [1 ]
机构：
[1] Univ Paris Est Creteil, UPEC EpiDermE EA, Creteil, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33567
引用
收藏
页码：AB88 / AB88
页数：1
相关论文
共 50 条
  • [41] The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, Bader
    Alzahrani, Ziyad
    Samarkandy, Sahal
    Aman, Abdullah
    Jfri, Abdulhadi
    FRONTIERS IN MEDICINE, 2023, 9
  • [42] ASSESSING THE LONGER-TERM EFFICACY OF BIOLOGIC THERAPIES AND APREMILAST FOR PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Sawyer, L.
    Fotheringham, I
    Comic, L.
    Yasmeen, N.
    Jemec, G.
    Levin, L.
    Hansen, J. B.
    Gibbons, C.
    Moller, A. H.
    Marques, R.
    VALUE IN HEALTH, 2017, 20 (09) : A801 - A801
  • [43] Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response
    Sawyer, L. M.
    Cornic, L.
    Levin, L. A.
    Gibbons, C.
    Moller, A. H.
    Jemec, G. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 355 - 366
  • [44] Estimated cost efficacy of FDA-approved systemic treatments for moderate-to-severe psoriasis
    D'Souza, Logan
    Payette, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB4 - AB4
  • [45] Deucravacitinib for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Toth, Otavio A. S.
    Meldola, Patrick F.
    Machado, Pablo G.
    Chiarelli, Gabriel F. C.
    Schnorrenberger, Erick
    Kracik, Jose L. S.
    de Carvalho, Caio C.
    Guzatti, Joao V. L.
    Mease, Philip J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (02) : 67 - 73
  • [46] Efficacy and Safety of AbobotulinumtoxinA for Treatment of Moderate-to-Severe Glabellar Lines: A Meta-Analysis
    Han, Xiaopan
    Bai, Jixian
    Kuang, Jing
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (02): : 126 - 133
  • [47] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Luis Puig
    Matthias Augustin
    Dermatology and Therapy, 2021, 11 : 885 - 905
  • [48] Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
    Lasa, Juan S.
    Olivera, Pablo A.
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 161 - 170
  • [49] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Armstrong, April W.
    Soliman, Ahmed M.
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    Puig, Luis
    Augustin, Matthias
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 885 - 905
  • [50] Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response
    Signorovitch, J. E.
    Betts, K. A.
    Yan, Y. S.
    LeReun, C.
    Sundaram, M.
    Wu, E. Q.
    Mulani, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (02) : 504 - 512
12345